Jeenjoo Kang

Chief Executive Officer at Appia Bio - , ,

Jeenjoo Kang's Contact Details
HQ
["2125202765","3107942200","13104038951"]
Location
San Francisco,California,United States
Company
Appia Bio
Jeenjoo Kang's Company Details
Appia Bio logo, Appia Bio contact details

Appia Bio

, , • 1 - 10 Employees
Biotechnology

Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

Details about Appia Bio
Frequently Asked Questions about Jeenjoo Kang
Jeenjoo Kang currently works for Appia Bio.
Jeenjoo Kang's role at Appia Bio is Chief Executive Officer.
Jeenjoo Kang's email address is ***@appiabio.com. To view Jeenjoo Kang's full email address, please signup to ConnectPlex.
Jeenjoo Kang works in the Research industry.
Jeenjoo Kang's colleagues at Appia Bio are Sean Allen, Jason Damiano, Alex Babayan, David Morse, Peiyuan Kang, Emily Lowe, Christopher Sakoda and others.
Jeenjoo Kang's phone number is ["2125202765","3107942200","13104038951"]
See more information about Jeenjoo Kang